课题基金 / 基金详情

Aging Vitamin E, and Immune Function in Aged

Aging Vitamin E, and Immune Function in Aged
维生素E的老化与老年人的免疫功能
批准号:
7274800
负责人:
SIMIN Nikbin MEYDANI
金额:
$26.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2010-08-31

项目摘要

项目成果

SIMIN Nikbin MEYDANI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):衰老与T细胞介导的功能下降有关,这导致感染性疾病和肿瘤的发病率、发病率和死亡率较高。T细胞中与年龄相关的缺陷已被证明是由于T细胞功能的内在下降,以及巨噬细胞(Mphi)产生的T细胞抑制因子前列腺素(PG)E2的增加。我们证明,增加PGE 2的生产是由于神经酰胺介导的上调环氧合酶2(考克斯-2)的转录,在PGE 2合成的关键调控酶。然而,神经酰胺上调考克斯2表达的信号机制尚不清楚,需要进一步研究。我们进一步表明,维生素E(E)补充通过两种不同的机制改善T细胞介导的功能:a)通过减少PGE 2产生,从而减少巨噬细胞Mphi介导的抑制,和B)通过直接增强T细胞功能,而不依赖于其对Mphi PGE 2产生的影响。E通过提高来自老年小鼠的幼稚T细胞产生IL-2的能力并通过细胞分裂周期进行发挥其作用。E诱导的初始T细胞功能增强的机制尚不清楚,需要确定。因此,这项建议的具体目标是: 1)确定神经酰胺诱导老年Mphi中考克斯-2表达上调的信号通路。为了实现这一目标,我们将检验神经酰胺通过增强PKC-zeta活性上调老年巨噬细胞中考克斯-2表达,导致IkappaB磷酸化增加,从而降解的假设。这反过来将增加NF κ B活化和考克斯-2表达。 2)确定E诱导老年初始T细胞功能增加的机制。为了实现这一目标,我们将测试的假设,E增强幼稚T细胞的功能,在老年小鼠,通过增加他们的能力,形成一个有效的免疫突触的T细胞受体(TCR)和抗原接触的网站。反过来,这将导致老年小鼠中TCR相关信号转导的改善,以及随后的IL-2产生。我们提出,E通过改变膜脂质结构域(称为脂筏)中关键TCR相关信号分子的再分布来诱导其效应,其机制为以下一种或两种:a)增加与TCR介导的活化相关的关键信号分子的棕榈酰化,和B)改变脂筏的脂质组分的结构。 这些实验将阐明与年龄相关的巨噬细胞和T细胞失调的机制,以及它们被E。反过来,这将有助于设计实用的营养干预措施,以逆转和/或延迟与年龄相关的免疫和炎症反应失调以及与之相关的疾病。
英文摘要
DESCRIPTION (provided by applicant): Aging is associated with a decline in T cell mediated functions, which contributes to a higher incidence of, and morbidity and mortality from, infectious diseases and tumors. The age-related defect in T cells has been shown to be due to intrinsic declines in T cell function, as well as increased production of prostaglandin (PG)E2, a T cell suppressive factor, by macrophages (Mphi). We demonstrated that the increased PGE2 production was due to ceramide mediated upregulation of cyclooxygenase 2 (COX-2) transcription, a key regulatory enzyme in PGE2 synthesis. The signaling mechanism through which ceramide upregulates COX 2 expression, however, is not known and needs to be investigated. We further showed that vitamin E (E) supplementation improves T cell mediated function by two distinct mechanisms: a) by decreasing PGE2 production, thus reducing macrophage Mphi mediated suppression, and b) by directly enhancing T cell function, independent of its effect on Mphi PGE2 production. E exerts its effect by improving the ability of naive T cells from old mice to produce IL-2 and progress through cell division cycles. The mechanism of E-induced enhancement of naive T cell function is not known and needs to be determined. Thus, the specific aims of this proposal are: 1) To determine the signaling pathway involved in ceramide-induced upregulation of COX-2 expression in old Mphi. To accomplish this goal, we will test the hypothesis that ceramide upregulates COX-2 expression in old macrophages through enhancing PKC-zeta activity, leading to increased IkappaB phosphorylation, and thus degradation. This in turn will increase NFkappaB activation and COX-2 expression. 2) To determine the mechanism of E-induced increase in the function of old naive T cells. To accomplish this goal, we will test the hypothesis that E enhances naive T cell function in old mice by increasing their ability to form an effective immune synapse at the site of T cell receptor (TCR) and antigen contact. This, in turn, will lead to improved TCR-associated signal transduction, and subsequent, IL-2 production in old mice. We propose that E induces its effect by changing the redistribution of key TCR associated signaling molecules in membrane lipid domains, known as lipid rafts, by one or both of the following mechanisms: a) increasing palmitoylation of key signaling molecules associated with TCR-mediated activation, and b) changing the structure of the lipid component of lipid rafts. These experiments will elucidate the mechanism of the age-related dysregulation of macrophages and T cells, as well as their normalization by E. This, in turn, will help in designing practical nutritional interventions to reverse and/or delay the age-associated dysregulation of immune and inflammatory responses as well as diseases associated with it.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0047650
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Molano A, Huang Z, Marko MG, Azzi A, Wu D, Wang E, Kelly SL, Merrill AH Jr, Bunnell SC, Meydani SN]
通讯作者: Meydani SN
Vitamin E and aging immune response.
维生素 E 和衰老免疫反应。
DOI: --
发表时间: 1995
期刊: Clinics in geriatric medicine.
影响因子: --
作者: [Meydani,SN, Hayek,MG]
通讯作者: Hayek,MG
Mechanism of age-associated up-regulation in macrophage PGE2 synthesis.
巨噬细胞 PGE2 合成中年龄相关上调的机制。
DOI: 10.1016/j.bbi.2004.05.003
发表时间: 2004
期刊: Brain, behavior, and immunity.
影响因子: --
作者: [Wu,Dayong, Meydani,SiminNikbin]
通讯作者: Meydani,SiminNikbin
Enhanced expression of inducible cyclooxygenase with age in murine macrophages.
小鼠巨噬细胞中诱导型环氧合酶的表达随着年龄的增长而增强。
DOI: --
发表时间: 1997
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Hayek,MG, Mura,C, Wu,D, Beharka,AA, Han,SN, Paulson,KE, Hwang,D, Meydani,SN]
通讯作者: Meydani,SN
共 13 条
    Zinc intervention in prevention of pneumonia in elderly
    • 批准号:
      10216609
    • 项目类别:
    • 资助金额:
      $33.98万
    • 财政年份:
      2021
    • 负责人:
      SIMIN Nikbin MEYDANI
    • 依托单位:
    Calorie Restriction and immune Response in Humans
    • 批准号:
      7596995
    • 项目类别:
    • 资助金额:
      $19.42万
    • 财政年份:
      2007
    • 负责人:
      SIMIN Nikbin MEYDANI
    • 依托单位:
    Calorie Restriction and immune Response in Humans
    • 批准号:
      8048976
    • 项目类别:
    • 资助金额:
      $18.96万
    • 财政年份:
      2007
    • 负责人:
      SIMIN Nikbin MEYDANI
    • 依托单位:
    Calorie Restriction and immune Response in Humans
    • 批准号:
      7244163
    • 项目类别:
    • 资助金额:
      $17.65万
    • 财政年份:
      2007
    • 负责人:
      SIMIN Nikbin MEYDANI
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: